Filgotinib
GS-US-433-5305
Phase 3 small_molecule terminated
Quick answer
Filgotinib for Ankylosing Spondylitis is a Phase 3 program (small_molecule) at Lakefront Biotherapeutics NV with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Lakefront Biotherapeutics NV
- Indication
- Ankylosing Spondylitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated